![Chinmaya Rath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chinmaya Rath
Corporate Officer/Principal bei GLYCOMIMETICS, INC.
Vermögen: 43 679 $ am 31.05.2024
Aktive Positionen von Chinmaya Rath
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GLYCOMIMETICS, INC. | Corporate Officer/Principal | - | - |
Catena Biosciences, Inc.
![]() Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Direktor/Vorstandsmitglied | - | - |
Cellurx | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Social Impact Capital, Inc.
![]() Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Private Equity Investor | 01.11.2022 | - |
Karriereverlauf von Chinmaya Rath
Ausbildung von Chinmaya Rath
Warwick Business School | Masters Business Admin |
Ravenshaw University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 2 |
Indien | 2 |
Operativ
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GLYCOMIMETICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Catena Biosciences, Inc.
![]() Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Commercial Services |
Cellurx | |
Social Impact Capital, Inc.
![]() Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
- Börse
- Insiders
- Chinmaya Rath
- Erfahrung